20645_Scapa_AR_160504

CORPORATE GOVERNANCE
of Group Finance Director. Paul has been
instrumental in leading the Group through
a period of exceptional growth and we
wish him well for the future. Graham brings
to the role very strong business skills and
experience in healthcare and global markets,
which will be of great benefit to the Group as
it pursues its strategy for growth. Graham
was Group Finance Director at Bridon
International and prior to that he held a
number of senior finance positions at Smith
& Nephew plc and Smiths Group plc.
Since the year end, we have also appointed
David Blackwood as an independent
Non-Executive Director. David was previously
Group Finance Director of Synthomer plc, a
position from which he retired in May 2015,
and prior to that was Group Treasurer at
Imperial Chemical Industries plc. David joined
the Board on 1 May 2016 and will chair the
Audit and Risk Committee from 1 June 2016.
Mike Buzzacott will stand down from the
Board on 30 May 2016.
As in prior years, we undertook a rigorous
evaluation of the Board and each of its
Committees. The conclusions from the
evaluation confirmed that the Board
continues to function effectively as a whole
and in Committee, and that all Directors
properly discharge their duties. During the
year, the Board took the decision that all
Directors will offer themselves for re-election
at each Annual General Meeting of the
Company. Richard Perry, Senior
Independent Director, has been in his
role since May 2006 and has indicated a
willingness to remain on the Board for a
further term subject to shareholder approval.
Richard is a highly valued member of the
Board and we wholeheartedly support his
continued tenure.
which were taken into account in finalising
the structure of the Value Creation Plan that
was approved by shareholders in General
Meeting on 16 November 2015. During the
year, I met with several major investors to
discuss Board composition, remuneration,
corporate governance and shareholder
relations. I am pleased to report that feedback
from these shareholder meetings, which are
held separately from the investor relations
meetings conducted by the Executive
Directors, was positive and supportive
of the business and management.
Lastly, I should like to encourage all
shareholders to attend the Annual General
Meeting on 19 July 2016, details of which
are enclosed with this report.
J A S WALLACE
CHAIRMAN
24 MAY 2016
Scapa is proud of the high standards of
corporate governance that it demands of
itself and its people. Before introducing
a new long term incentive plan for the
Executive Directors and Executive Team, the
Chairman of the Remuneration Committee
and the Company Secretary liaised with the
top ten shareholders to canvass views,
35
ANNUAL REPORT AND ACCOUNTS 2016 SCAPA GROUP PLC